Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-01-04$9.87/sh−5,437$53,663→ 64,243 total - Award
Stock Option (Right to Buy)
2023-01-04+80,000→ 80,000 totalExercise: $9.87Exp: 2033-01-04→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
- [F2]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.